AI Offers Hope for Earlier Screening for Type 1 Diabetes

IBM researchers launch the first in-depth, large scale study of time courses when different antibodies appear, and their correlations to type 1 diabetes.

Continue reading

IBM and Johns Hopkins University School of Medicine Discover Unique, Pathogenic Autoimmune Cells in Type 1 Diabetes

Researchers at JHU and IBM identify new cells involved in the autoimmune attack on insulin-producing cells in type 1 diabetes.

Continue reading

JDRF and IBM piece together the puzzle of type 1 diabetes

Health-related information is the new frontier of data, and machine learning is one of the most powerful data-analysis tools available. When you put them together, you can glean valuable insights about health and human disease. JDRF and IBM announced today they are collaborating to focus this power on preventing the autoimmune disease type 1 diabetes […]

Continue reading